Dr. Robert A. Nagourney, MD
Why Do Chemotherapy Drugs Work For Some Cancer Patients and Not For Others?
Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.
top of page
Cancer Blog
- Dr. Robert Nagourney -
Search
Dr. Robert A. Nagourney, MD
Sep 262 min read
Metastatic Breast Cancer Claims Another Life
I received a video from an episode of Americas Got Talent, the popular TV program that features up-and-coming performers.
Dr. Robert A. Nagourney, MD
Sep 53 min read
Stage 4 Cancer Patients Need Answers Not Questions: Genomic Variants Of Uncertain Significance (VUS) Don’t Help!
Genomic findings are a first step. They find targets. The question the patient wants to answer is “Can I hit the target?”
Dr. Robert A. Nagourney, MD
Jun 132 min read
For Pancreatic Cancer Patients, “the More You Explain It, The More I Don’t Understand It.” -Mark Twain
Even here in the potentially curable
pancreatic cancer patients, there is a great deal of disagreement on the best treatment.
Dr. Robert A. Nagourney, MD
Mar 122 min read
What’s a Pancreatic Cancer Doctor to do? More Importantly: What are Their Patients to do?
Screening for Pancreatic cancer, even in the highest-risk individuals found not cost effective.
Dr. Robert A. Nagourney, MD
Mar 42 min read
Breakthrough in Pancreatic Cancer: New Blood Test for Early Detection, Could Offer Improved Therapy
Blood test results offer a “cancer signature” that distinguishes patients with pancreatic cancer from normal individuals.
Dr. Robert A. Nagourney, MD
Feb 212 min read
Much Heralded New Treatment For Pancreatic Cancer Approved by FDA: But Has it Moved The Dial?
The NAPOLI-3 trail trial median survival of 11.1 months is exactly the same as the original FOLFIRINOX regimen from 13 years ago.
Dr. Robert A. Nagourney, MD
Feb 92 min read
Functional Profiling for Cancer is Scientifically Validated by Peer-Review
One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.
Dr. Robert A. Nagourney, MD
Jan 313 min read
What Have Medical Oncologists Lost? Empathy!
Cancer patients approach their diagnosis with a sense of terror. One day they are fine and feeling well and the next, a terminal diagnosis.
Dr. Robert A. Nagourney, MD
Jan 233 min read
For Advanced Cancer Patients: Whose Life is It Anyway?
Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.
Dr. Robert A. Nagourney, MD
Jan 152 min read
Personalized Medicine Is More Than a Marketing Buzzword at Nagourney Cancer Institute
Cancer therapy can be really expensive. But here's the kicker, Functional Profiling costs way less than receiving the incorrect treatment.
Dr. Robert A. Nagourney, MD
Dec 7, 20232 min read
The Cancer Clinical Trial Process is in Need of Revision
Patients with advanced malignancies often seek the expertise of physicians at major institutions.
Dr. Robert A. Nagourney, MD
Oct 30, 20233 min read
Hitting Cancer True and Straight: the Role of Tissue Analysis
Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...
Dr. Robert A. Nagourney, MD
Sep 26, 20232 min read
Your Cancer Cure May Already Exist
Personalized treatment means more cured patients. More people survive cancer when our Functional Profiling system is used before treatment.
Dr. Robert A. Nagourney, MD
Aug 30, 20232 min read
Pancreatic Cancer Surgery: Know What You Have Consented To!
However, a new dilemma has arisen; the failure of surgeons to comply with Pancreatic Cancer patient’s wishes to have tissue submitted.
Dr. Robert A. Nagourney, MD
Aug 14, 20233 min read
“New” Immune Therapy Active in Late-Stage Cancer Patients
Here in 2023, we
suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.
Dr. Robert A. Nagourney, MD
Jul 24, 20232 min read
Stage 4 Cancer Patient Survivals: The Data Is In and It’s Not Good
There has been talk of improved survival in cancer, most progress has reflected screening, early diagnosis, improved staging, and support.
Dr. Robert A. Nagourney, MD
Jun 26, 20233 min read
Challenging Paradigms: The Management of Rectal Cancer
One noteworthy case was a 78-year-old patient successfully treated without surgery.
Dr. Robert A. Nagourney, MD
Jun 2, 20232 min read
Breakthrough for Young Patients with a Rare Form of Liver Cancer
Extremely rare liver cancer that mostly affects people in their twenties associated with a gene rearrangement, mostly lethal, until now.
Dr. Robert A. Nagourney, MD
May 19, 20233 min read
For Medical Oncology, Déjà Vu All Over Again
Patients are being encouraged to contact the researchers to get biopsies and help take charge of their disease.
bottom of page